αStock Quant AI
ResearchAPI
  1. Home
  2. /
  3. Research
  4. /
  5. JPM

Equity Research · Wednesday, October 14, 2026

JPMHoldEqual Weight

JPM Stock Analysis for October 2026

JPMorgan Chase & Co.


Price at Analysis

$331.43
1Y Target$340.00+2.6%
3Y Target$395.00+19.2%

1Y Price Target

$340.00

+2.6%

vs current price

Technical Setup

RSI 37 / bearish MACD

Support context: $279.10. Resistance context: $366.50.

Valuation Snapshot

P/E ~15.0x TTM (~13x forward) / P/S ~4.4x (est.)

Market cap $888.63B; revenue $50.9B Q3 managed (+8% YoY).

Risk Watch

Expense creep and efficiency erosion

Expenses +12% YoY vs revenue +8%; management raised expense guide alongside NII guide. Volume-related costs, compensation, and tech/front-office investment suggest structural cost pressure limiting positive operating leverage.

01 · Summary

Executive Summary

JPMorgan Chase remains the best-run U.S. money-center bank by almost every operating metric — 20% ROTCE, 17% ROE, 13.9% CET1, $5.0T balance sheet, $2.71T deposits and #1 IB fee share at 8.4% — and Q3 2026 grew managed revenue 8% YoY to $50.9B with net income of $15.3B (+6% YoY). Yet the quarter was a rare miss: GAAP EPS $5.57 ($5.75 ex-significant item) vs $5.90-$5.94 consensus and revenue $50.17-$50.9B vs $51.3-$51.97B expected, driven by softer fixed-income/IB, a 12% surge in expenses to $27.3B outpacing revenue, and a pullback in buybacks that management framed as capital caution. Morningstar's response — raising fair value to $330 and rating 3-stars — captures the tension: a wide-moat compounder that is now fairly valued after a run to $366.50. With the stock at $331.43, down 9.6% from highs and 6% in the last month on high Treasury yields and macro uncertainty, risk/reward looks balanced. NII strength (+13% YoY to $27.1B, FY guide raised to ~$105.5B) and fortress capital/dividend growth offset margin pressure and capital-markets cyclicality, supporting a Neutral stance with modest upside to fair value plus dividends.

02 · Scenario Modeling

Price Targets

1Y Base Target

$340.00+2.6%

3Y Base Target

$395.00+19.2%

1-Year scenario price targets · Dashed line = current price

02 · Scenario Modeling

Scenario Analysis

Scenario1Y Target1Y Growth3Y Target3Y Growth
↑↑Hyper Bull
$420.00+26.7%$520.00+56.9%
↑Bull
$375.00+13.1%$440.00+32.8%
→Neutral
$340.00+2.6%$395.00+19.2%
↓Bear
$295.00-11.0%$280.00-15.5%
↓↓Hyper Bear
$240.00-27.6%$200.00-39.7%
↑↑Hyper Bull
1Y$420
3Y$520
1Y %+26.7%
3Y %+56.9%
↑Bull
1Y$375
3Y$440
1Y %+13.1%
3Y %+32.8%
→Neutral
1Y$340
3Y$395
1Y %+2.6%
3Y %+19.2%
↓Bear
1Y$295
3Y$280
1Y %-11.0%
3Y %-15.5%
↓↓Hyper Bear
1Y$240
3Y$200
1Y %-27.6%
3Y %-39.7%
Hyper Bull — NII beats $110B+, IB supercycle returns with double-digit fee growth, expenses controlled for positive leverage, ROTCE sustains 22-23%. Multiple re-rates to 16-17x on quality premium plus aggressive buybacks resume. Requires soft landing, rate cuts without recession, and benign credit.
Bull — Durable NII, resilient credit with lower provisions, and CIB recovery drive mid-teens EPS growth. 13x forward proves cheap for 20% ROTCE compounder; dividend + buybacks drive 13%+ 1Y total return and new highs above $366.50.
Neutral — Fairly valued wide-moat bank grows earnings high-single digits but expense growth and choppy capital markets cap multiple expansion. Stock tracks fair value ~$330-$340 plus dividend, compounding to ~$395 in 3 years on retained earnings and modest buybacks.
Bear — Margin pressure persists as 12% expense growth outruns NII, IB/FICC stays soft, and buyback restraint continues. Credit normalization accelerates provisions, ROTCE fades to mid-teens, multiple compresses to 11-12x. Down ~11% in 1Y with underperformance vs peers.
Hyper Bear — Hard landing/recession: loan losses spike, deposits reprice, NII falls, markets revenue collapses, capital build halts distributions. Fortress prevents failure but earnings fall 30%+, multiple to 9-10x trough, down ~28% in 1Y with multi-year repair.

03 · Fundamentals

Key Financial Metrics

Earnings Per Share (EPS)
$5.57 GAAP ($5.75 ex-item) vs $5.90-$5.94 est.
Beta
1.10 (est.)
Revenue
$50.9B Q3 managed (+8% YoY)
P/E Ratio
~15.0x TTM (~13x forward)
P/S Ratio
~4.4x (est.)
Market Cap
$888.63B
Net Income
$15.3B Q3 (+6% YoY)
Dividend Yield
~1.8% (10% hike, 27% payout)
Short Interest
N/A (no elevated short data reported)
52-Week Low
$279.10
52-Week High
$366.50

02 · Scenario Modeling

Technical Overview

Quant overlays derived from the existing 1Y OHLCV series: trend stack, sigma bands, regression fit, drawdown regime, and a composite signal model.

RSI (14)

37.3

Momentum Stack

1M -5.3% / 3M -4.5%

Volatility Regime

16.6% 20D vol

Regression Fit

-3.6% vs trend

Close20D MA50D MA200D MABollinger (20, 2σ)Regression channel centerline

Drawdown Curve

Distance from rolling peak, useful for regime stress and recovery speed.

-9.2%

Trend Regime

neutral

Mixed stack

Composite Signal

neutral

Neutral (-2)

Mean Reversion

neutral

-0.86 sigma

Breakout Status

neutral

Inside channel

Range Percentile

neutral

60th pct

Volume Impulse

bullish

1.62x 20D avg

Quant Dashboard

A compact read on trend persistence, stretch, realized risk, and breakout behavior.

1M Return
-5.3%
6M Return
+6.5%
1Y Return
N/A
ATR (14)
$5.54
20D Vol
16.6%
60D Vol
17.2%
Regression R²
0.44
Price Z-Score
-0.86
52W High
$366.50
52W Low
$279.10
Range Position
60th pct
Latest Volume
13.8M

04 · Research

Micro Analysis

Operating excellence intact but Q3 revealed margin and capital-allocation friction: revenue growth more than offset by expense growth and a miss on both lines.

Q3 miss despite YoY growth

Q3 managed revenue $50.9B (+8% YoY, +6.5% to $50.17B on reported basis) and diluted EPS $5.57 (+9.9-10% YoY from $5.07) both missed consensus ($5.90-$5.94 EPS, $51.3-$51.97B revenue). CIB softened markedly vs strong Q2, with lower fixed-income markets only partly offset by equities revenue +49% to $22.7B CIB revenue and higher deposits/wholesale loans.

Industry-leading profitability with deteriorating efficiency

ROE 17%, ROTCE 20% (23% cited pre-Q3) remains best-in-class vs peers. However noninterest expense $27.3B +12% YoY on volume-related costs and front-office investment outpaced 8% revenue growth, deteriorating overhead ratio. Management raised both NII guidance and expense forecast, implying net margin pressure ahead.

Fortress balance sheet and shareholder return shift

CET1 Standardized 13.9%, Advanced 14.1%, $303B total capital, $5.0T assets, $2.71T deposits, $7.6T client assets in AWM. Dividend raised 10% with 15-16 year consecutive growth, 27% payout ratio. Offsetting positive: Dimon cut buyback pace despite $50B authorization — the 'bigger story' signaling valuation discipline and capital caution ahead of Basel/credit normalization.

Franchise scale and diversification

Three segments (CCB with 5,000+ US branches, CIB with 8.4% IB fee share ranked #1 globally, AWM) plus money-market ETF (JMMF) benefit. Each line of business grew in Q3. Scale supports durable NII ($27.04-$27.1B in Q3, +13% YoY) driven by deposit franchise and balance-sheet strength, not just rates.

Valuation at fair value

At $888.63B market cap (~15x TTM ~$22 EPS, ~13x forward P/E per bulls, ~4.4x sales), stock trades essentially at Morningstar fair value $330 (3-star, Wide Moat, Medium Uncertainty). Wall Street Moderate Buy with 14% upside target is historically bullish-skewed and already dented by 6%+ pullback and YTD only +3.3%.

04 · Research

Macro Analysis

Higher-for-longer rates help NII but hurt capital markets, credit costs, and multiples; Dimon warnings on hikes and economy frame balanced macro.

Higher rates + high Treasury yields: double-edged

Net interest income +13% YoY and FY guide to $105.5B (+2.3% sequential for large banks expected) supported by higher deposit/loan balances. Conversely, multidecade-high bond yields weighed sentiment, drove 6%+ pullback, pressured IB/debt underwriting and equity multiples.

Capital markets softening after hot start

Scorching H1 capital markets cooled in Q3; JPM CIB softened markedly from Q2 robust pace. Trading strength (equities +49%) offset weaker FICC/IB, but volatility in markets revenue makes forward earnings less predictable.

U.S. economy solid but CEO cautious

Management described U.S. economy as solid, small-business optimism dipped in September. Dimon warned of risks from further rate hikes, inflation clouding outlook, and underlying economic concerns — consistent with building capital (13.9% CET1) rather than maximizing buybacks.

Credit normalization manageable so far

Provisions lower with improved card charge-off outlook cited by bulls, reflecting resilient consumer. Risk is lagged effect of higher rates on wholesale/commercial and consumer delinquencies if labor weakens; strong reserves provide buffer but limit operating leverage.

Bank earnings tape mixed

Oct 13 bank earnings drove mixed trading with chip pressure; JPM slid 3.8% premarket then finished flat to +1% near $338 intraday before closing $331.43 on 13.76M volume below VWAP $335. Shows market indecisive on beats vs misses across large-caps.

05 · Growth

Untapped Revenue Opportunities

NII durability from deposit franchise

high

Higher deposit and wholesale loan balances drove 13% NII growth; raised FY NII outlook to ~$105.5B. $2.71T deposits and 5,000-branch network provide low-cost funding advantage even if Fed pauses.

CIB rebound and #1 IB share

medium

8.4% global IB fee share leaves JPM best positioned for M&A/DCM/ECM recovery. Equities trading record (+49%) shows ability to monetize volatility; any capital-markets re-acceleration drops high-margin fees.

Asset & Wealth Management scaling

medium

$7.6T client assets plus money-market ETF demand (JMMF) amid high cash yields drive recurring fee income, less capital-intensive than lending and supports ROTCE expansion.

06 · Catalysts

Headwinds & Tailwinds

↓ Headwinds

Expense creep and efficiency erosion

high

Expenses +12% YoY vs revenue +8%; management raised expense guide alongside NII guide. Volume-related costs, compensation, and tech/front-office investment suggest structural cost pressure limiting positive operating leverage.

Buyback pullback signals capital/valuation cap

medium

Despite $50B authorization and $303B capital, Dimon slowed repurchases. Implies stock not cheap at 13-15x earnings, regulatory (Basel) buffer needs, or caution on credit — removes key EPS support that powered prior outperformance.

Capital-markets cyclicality and rate/inflation risk

medium

Q3 FICC/IB softness shows dependence on markets; further rate hikes or sticky inflation could invert benefit (higher credit costs, lower loan growth, lower multiples). CEO explicitly flagged these risks.

↑ Tailwinds

Best-in-class profitability and moat

high

20% ROTCE, 17% ROE, Wide Moat rating, global scale in 66 countries with 320,560 employees. Allows premium multiple vs peers and resilience through cycles.

Fortress capital + dividend compounder

medium

13.9% CET1, 27% payout, 10% dividend hike, 15-16 years growth, $50B repurchase capacity. Supports total return even when price flat; dividend safety high.

Oversold technical reset

medium

RSI 37.3, -9.6% off $366.50 high, -6% last month, YTD +3.3% lagging prior momentum. Washout of crowded positioning after miss creates cleaner entry vs chasing highs; Morningstar fair value $330 now acts as support.

07 · TL;DR

Analysis Summary

Ticker
JPM
Company
JPMorgan Chase & Co.
Analysis Date
2026-10-14
Price at Analysis
$331.43
Rating
Hold
1Y Price Target
$340.00
3Y Price Target
$395.00
Market Cap
$888.63B
P/E Ratio
~15.0x TTM (~13x forward)

This analysis was generated on 2026-10-14 when JPM was trading at $331.43. The base-case 1-year price target is $340.00 (+2.6% implied return). Scenario range: $240.00 (hyper bear) to $420.00 (hyper bull).

Disclaimer: This report is generated by an AI model and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Past performance is not indicative of future results. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Keep Reading

More Research

IPSell

International Paper Co.

2026-10-14

UNHBuy

UNITEDHEALTH GROUP INCORPORATED (Delaware)

2026-10-14

RRSell

Richtech Robotics Inc. Class B Common Stock

2026-10-13

Stock Quant AI
SupportBuilt by John Leonardo · Not financial advice.